Template:Update
2019-nCoV symptoms
of hospitalized patients[1] ()
| Signs and symptoms at admission
|
| Fever |
82 (83%)
|
| Cough |
81 (82%)
|
| Shortness of breath |
31 (31%)
|
| Muscle ache |
11 (11%)
|
| Confusion |
9 (9%)
|
| Headache |
8 (8%)
|
| Sore throat |
5 (5%)
|
| Runny nose |
4 (4%)
|
| Chest pain |
2 (2%)
|
| Diarrhoea |
2 (2%)
|
| Nausea and vomiting |
1 (1%)
|
| More than one sign or symptom |
89 (90%)
|
| Fever, cough, and shortness of breath |
15 (15%)
|
| Complications |
33 (33%)
|
| ARDS |
17 (17%)
|
| Acute kidney injury |
3 (3%)
|
| Acute lung injury |
8 (8%)
|
| Septic shock |
4 (4%)
|
| Ventilator-associated pneumonia |
1 (1%)
|
| Medical imaging
|
| Unilateral pneumonia |
25 (25%)
|
| Bilateral pneumonia |
74 (75%)
|
| Multiple mottling and ground-glass opacity |
14 (14%)
|
| *: Patients n=99.
|
Notes
References
These references will appear in the article, but this list appears only on this page.
- ↑ Chen, Nanshan; Zhou, Min; Dong, Xuan; Qu, Jieming; Gong, Fengyun; Han, Yang; Qiu, Yang; Wang, Jingli; Liu, Ying; Wei, Yuan; Xia, Jia'an; Yu, Ting; Zhang, Xinxin; Zhang, Li (30 January 2020). "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study". The Lancet. doi:10.1016/S0140-6736(20)30211-7.
|
|---|
|
|
|
Institutions |
|---|
Centers for Disease Control | |
|---|
Hospitals and related | |
|---|
| Organisations | |
|---|
|
|
|
People |
|---|
Medical professionals/ whistleblowers | |
|---|
| Researchers | |
|---|
| Officials |
|
|---|
| Others | |
|---|
| Infected | |
|---|
|
|
Data |
|---|
| Global | |
|---|
| Africa | |
|---|
| Asia | |
|---|
| Europe | |
|---|
| North America | |
|---|
| Oceania | |
|---|
| South America | |
|---|
|
|
|